Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/24/2025

Diuretic Management for Pleural Effusion

Etiology-Driven Approach

  • The American College of Cardiology recommends starting with furosemide 20-40 mg once or twice daily, increasing until urine output increases and weight decreases by 0.5-1.0 kg daily, for confirmed heart failure with fluid retention 3, 4
  • The maximum furosemide dose is 600 mg/day 4
  • Alternative loop diuretics include torsemide 10-20 mg once daily, which may have superior absorption and longer duration of action, and bumetanide 0.5-1.0 mg once or twice daily 3, 4
  • Thiazide diuretics, such as metolazone 2.5 mg once daily, can be added for refractory cases 4
  • Diuretics should be combined with ACE inhibitors and beta-blockers, never used alone, and continued until all clinical evidence of fluid retention resolves 3

ARDS/Critical Care Context

  • For mechanically ventilated ARDS patients without shock, a conservative fluid strategy with protocolized diuretic administration should be used, starting with furosemide 20 mg bolus or 3 mg/hour infusion 5
  • The dose should be doubled each subsequent time until goal achieved or maximum infusion rate of 24 mg/hour or 160 mg bolus reached 5
  • Diuretics should be withheld in renal failure and until 12 hours after last fluid bolus or vasopressor 5

Non-Fluid Overload Etiologies

  • The American Thoracic Society recommends that diuretics are ineffective and potentially harmful for malignant pleural effusions, which require thoracentesis, indwelling pleural catheter, or pleurodesis 1, 2
  • Diuretics are also ineffective for parapneumonic effusions/empyema, which require chest tube drainage when pH ≤7.2 or LDH >900 IU/L 1, 2
  • Tuberculous effusions require anti-tuberculous therapy 1, 2

Critical Pitfalls to Avoid

  • Using inappropriately low diuretic doses leads to persistent fluid retention, diminishing response to ACE inhibitors and increasing risk with beta-blockers 3
  • Using inappropriately high diuretic doses causes volume contraction, increasing hypotension risk with ACE inhibitors and renal insufficiency with ACE inhibitors/ARBs 3
  • Stopping diuretics prematurely due to mild azotemia or hypotension before fluid retention fully resolves 3
  • Using diuretics as monotherapy in heart failure—they must be combined with neurohormonal blockade 3

Monitoring Requirements

  • Daily weights, serum electrolytes, renal function, volume status, and blood pressure should be tracked 3